No Data
No Data
Legend Biotech Price Target Maintained With a $90.00/Share by Piper Sandler
Legend Biotech Price Target Maintained With a $90.00/Share by Piper Sandler
Express News | Piper Sandler Reiterates Overweight on Legend Biotech, Maintains $90 Price Target
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
Shares of cell therapy company Legend Biotech Corp (NASDAQ:LEGN) were trading lower on Monday, after being among the top pharma gainers in the first week of June.The company's Carvykti drug is likely
Truist Financial Initiates Legend Biotech(LEGN.US) With Buy Rating, Announces Target Price $88
Truist Financial analyst Asthika Goonewardene initiates coverage on $Legend Biotech(LEGN.US)$ with a buy rating, and sets the target price at $88.According to TipRanks data, the analyst has a success
Legend Biotech Initiated at Buy by Truist Securities
Legend Biotech Initiated at Buy by Truist Securities
Piper Sandler Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $90
Piper Sandler analyst Edward Tenthoff maintains $Legend Biotech(LEGN.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 0.0% an